Condition

Myelitis, Transverse (3)

Neuromyelitis Optica (2)

Autoimmune Diseases of the Nervous System (1)

Demyelinating Autoimmune Diseases, CNS (1)

Flaccid Paraplegia, Complete, Acute (1)

Flaccid Paraplegia, Incomplete, Acute (1)

Overall Status

Completed (2)

Terminated (1)

Phase

phase 3 (1)

phase 4 (1)

Sponsor

Guy's and St Thomas' NHS Foundation Trust (1)

State University of New York at Buffalo (1)

University of Texas Southwestern Medical Center (1)

Intervention

intravenous immunoglobulin (1)

intravenous methylprednisolone (1)

mitoxantrone (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational [Patient Registry] (1)

myelitis, transverse

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Myelitis, Transverse, Flaccid Paraplegia, Complete, Acute, Flaccid Paraplegia, Incomplete, Acute Trial in Dallas

Completed

Myelitis, Transverse
+2 more

Dallas, Texas

UTexasSouthwestern

Aug 22, 2022

Neuromyelitis Optica, Myelitis, Transverse, Demyelinating Autoimmune Diseases, CNS Trial in Buffalo (Mitoxantrone)

Completed

Neuromyelitis Optica
+3 more

Mitoxantrone

Buffalo, New York

Baird Multiple Sclerosis Center

Dec 23, 2020

Myelitis, Transverse, Neuromyelitis Optica Trial in United Kingdom (Intravenous Methylprednisolone, Intravenous Immunoglobulin)

Terminated

Myelitis, Transverse
Neuromyelitis Optica

Intravenous Methylprednisolone
Intravenous Immunoglobulin

Birmingham, United Kingdom
+17 more

Jul 18, 2016